Marino, Stram & Associates LLC Vertex Pharmaceuticals Inc Transaction History

Marino, Stram & Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$181.39 - $202.99 $185,561 - $207,658	-1,023 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$187.49 - $221.1 $191,802 - $226,185	1,023 New	1,023 $206,000
Q2 2019 Jul 19, 2019	SELL	$164.61 - $190.37 $3,786 - $4,378	-23 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $3,351 - $3,909	23 New	23 $4,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Marino, Stram & Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Marino, Stram & Associates LLC with notifications on news.